Citadel Advisors’s Neos Therapeutics, Inc NEOS Stock Holding History

Citadel Advisors’s Portfolio NEOS Stock Details NEOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-13,200	Closed	-$64K	–	10066
2018 Q3	$64K	Buy	+13,200	New	+$74.9K	﹤0.01%	8746

Citadel Advisors's NEOS Position: Q4 2020 in Review

Citadel Advisors sold out of Neos Therapeutics, Inc (NEOS) in Q4 2020, closing a stake of 10,705 shares — an estimated $6.61K sold.

Citadel Advisors first reported a position in NEOS in Q4 2015 and held it in 10 quarters. The position peaked at $617K in Q3 2017. 37 funds tracked by Wall St. Rank hold NEOS as of Q4 2020.

Citadel Advisors reported no remaining Neos Therapeutics, Inc position as of Q4 2020 after selling out during the quarter.
Citadel Advisors sold 10,705 Neos Therapeutics, Inc shares in Q4 2020, an estimated $6.61K.
Citadel Advisors first reported a position in Neos Therapeutics, Inc in Q4 2015 and held it in 10 quarters.
Citadel Advisors's Neos Therapeutics, Inc position peaked at $617K in Q3 2017.
37 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q4 2020.

Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.